Frontlight ResearchEarly access
Trial site
University of California, Irvine Medical Center
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Epilepsy1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Huntington's disease1 trial
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- and 4 more
- Phase
- Phase 1/23 trials
- Phase 23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- AskBio Inc1 trial
- CHDI Foundation, Inc.1 trial
- Dragonfly Therapeutics1 trial
- enGene, Inc.1 trial
- Epiminder America, Inc.1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Active, not recruiting
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Active, not recruiting
Recruiting
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Epilepsy1 recruiting
- Follicular lymphoma1 recruiting
- Huntington's disease1 recruiting
- Myasthenia gravis1 recruiting
- Pompe disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026